HIVdent.org | HIV Testing & Prevention

Last Updated: November 23, 2023

*Featured Articles*
	Primary Care Clinicians Should Spearhead HIV Prevention Medscape \| September 19, 2023
	USPSTF Gives 'A' Rating to All 3 Approved PrEP Medications, but Access Challenges Remain Infectious Disease Special Edition \| September 1, 2023
	New USPSTF Recommendations for HIV PrEP Should Expand Coverage of Affordable Drugs Everyday Health \| August 25, 2023
	Factors Associated With Long-Term Adherence to Daily HIV PrEP Among MSM Infectious Disease Advisor \| July 7, 2023
	Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis NIH \| PubMed \| July 4, 2023
	AIDSVu Releases 2022 PrEP Use Data by Race/Ethnicity AIDSVu \| June 21, 2023
	US Preventive Services Task Force recommends PrEP for HIV prevention The Hill \| December 14, 2022
	10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups Contagion Live \| August 2, 2022
	AIDSVu Releases New Data Showing Significant Inequities in PrEP Use Among Black and Hispanic Americans AIDSVu \| july 29, 2022
	HIV Prevention Drugs Work Great. Why Is Access So Inequitable? Everyday Health \| July 13, 2022



Courtesy of NATAP
	Predicted uptake of novel HIV treatment options in the United States - (10/16/23)
	Factors driving decisions in the use of HIV Pre-Exposure Prophylaxis: Data from a real-world study in the United States - (10/16/23)
	Increase in New HIV Diagnoses Following Decrease in Use of Pre-exposure Prophylaxis (PrEP) During the COVID-19 Pandemic - (10/16/23)
	The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US - (10/16/23)
	Evaluating Pre-Exposure Prophylaxis Use in a Large Integrated Rural US Health System - (10/16/23)
	Facilitators and Barriers to Engaging in PrEP and Gender Affirming Therapy for Black and Latina Transgender Women in South Florida - (10/16/23)
	A Quality Improvement Initiative for HIV Prevention in Underserved Communities - (10/16/23)
	Risk Factors, Risk Perception, and Long-Acting PrEP Awareness and Interest Among US Women: A National Survey - (10/16/23)
	Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Role of Social-Structural Factors - (10/16/23)
	Integrating Long-Acting Injectable Cabotegravir for PrEP Into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex With Men: Results From the PILLAR & EBONI Studies - (10/16/23)
	Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women - (10/16/23)
	Healthcare Staff Perceptions of Feasibility and Acceptability on Implementing Injectable HIV Pre-exposure Prophylaxis Into Standard of Care: Baseline Results From the PrEP Implementation Study for Cabotegravir Long Acting for Men in the Real World (PILLAR) - (10/16/23)
	Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool (SDT) for Diverse Populations and Healthcare Providers - (10/13/23)


*Helpful Tools*
	Finding The Best At Home Std Test
	AAHIVM Routine Testing Coding Guide
	The AAHIVM Coding Guide to Routine HIV Testing
	Dentists' Willingness to Provide Expanded HIV Screening in Oral Health Care Settings: Results From a Nationally Representative Survey Am J Public Health. 2014 Mar 13
	Caring for Veterans with HIV
	Linkage to Care: Linking newly diagnosed HIV-infected persons to Medical Providers through Linkage to Care Case Management (LTC)
	State HIV Testing Laws
	How to Apply for a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver
	Rapid HIV Testing - CDC
	Evaluation of a Rapid HIV Testing Initiative in an Urban, Hospital-Based Dental Clinic
	HIV Rapid Test OraQuick Advance HIV1/2 Protocol
	Coding Guidelines for Routine HIV Testing in Health Care Settings (courtesy of AAHIVM)
	Clinical Laboratory Improvement Admentments (CLIA) Application for Certificate
	OraQuick ADVANCE® HIV-1/2 Test Result Panel Training

*News Updates*
	Pre-exposure prophylaxis (PrEP) use history in people with antiretroviral resistance at HIV diagnosis: Findings from New York City HIV... Oxford Academic \| November 17, 2023
	Bc Centre For Excellence In Hiv/Aids Launches New Initiative Targeting Sexually Transmitted Infections in BC Yahoo Finance \| November 17, 2023
	Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection... The Lancet \| November 9, 2023
	Science Update: Generic Daily HIV Prevention Pill for Young Men Who Have Sex with Men ... HIV.gov \| November 6, 2023
	No Longer a Death Sentence, HIV Diagnosis Still Hits Hard Medscape \| November 6, 2023
	HIV/AIDS: Meeting Unmet Needs in Treatment and Prevention United Nations \| November 6, 2023
	HRSA EHE PrEP data from community health centers (excel) HIV+HEP Policy Institute \| October 19, 2023
	More than a third of eligible beneficiaries on PrEP for HIV, but disparities persist The Hill \| October 17, 2023
	PrEP, a Key HIV Prevention Tool, Isn’t Reaching Black Women KFF Health news \| October 12, 2023
	Missed Chances for Screening in Persons Newly Diagnosed with HIV: New York City, 2018–2022 NEJM \| September 26, 2023
	HIV Testing Post-Pandemic: Implications to Ending the HIV Epidemic Plan Infectious Disease Special Edition \| September 1, 2023
	Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral... BMC Public Health. 2023 Aug 28;23(1):1643. doi: 10.1186/s12889-023-16382-4
	PrEParing for the End of the HIV Epidemic—A Public Health Imperative \| Guidelines JAMA Network \| August 22, 2023
	Is Higher Adherence Required for Women using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Preexposure... Clin Infect Dis. 2023 Aug 17;ciad485. doi: 10.1093/cid/ciad485
	Pre-Exposure Prophylaxis Continues to be Effective in Preventing HIV, Certain Populations ... Pharmacy Times \| August 9, 2023
	Preparing for long-acting PrEP delivery: building on lessons from oral PrEP J Int AIDS Soc. 2023 Jul;26 Suppl 2:e26103. doi: 10.1002/jia2.26103.
	Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who... J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26096. doi: 10.1002/jia2.26096.
	PrEP Implant That Protects Against HIV Could Be Near USNews.com \| June 29, 2023
	Disparities in HIV Prevention: New Data Reveal Racial and Regional Gaps in PrEP Usage Contagion Live \| June 28, 2023
	Urging the CDC to Recommend HIV Testing for People 65 and Older POZ Magazine \| June 20, 2023
	Dried blood spot test can detect HIV and hepatitis, researchers say Healio \| April 24, 2023
	PrEP for women in Europe: a systematic literature review HIV Med. 2023 Apr 23. doi: 10.1111/hiv.13458
	DoD Rolls Out Updated HIV PrEP Information HIV.gov \| April 5, 2023
	Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States... J Int AIDS Soc. 2023 Mar;26(3):e26077. doi: 10.1002/jia2.26077.
	Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women - PubMed (nih.gov) AIDS Patient Care STDS. 2023 Mar 24. doi: 10.1089/apc.2023.0009
	Study examines parental concerns of their sexual and gender minority adolescents using PrEP News Medical \| March 2, 2023
	CDC-UNC Collaboration Yields Potential Long-term HIV Protection UNC Health and UNC School of Medicine \| February 9, 2023
	Agents of change: Long-acting formulations for prevention and treatment of HIV MSF Access Campaign \| February 2, 2023
	Study Suggests Side-Effects and Costs Are Biggest Concerns for Users of HIV Pre-Exposure ... Newswise \| January 31, 2023
	Inconsistent Implementation Of The ACA’s Preventive Services Coverage Requirement Has Resulted In Differential, Unfavorable Coverage For PrEP Health Affairs \| January 26, 2023
	Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir ... The Lancet \| January 17, 2023
	Long-acting PrEP injections could help reduce new cases of HIV in United States Imperial College London \| January 17, 2023
	New York Insurance Companies Now Required to Cover PrEP HIVPlusMag.com \| December 25, 2022
	HIV/AIDS Organizations Call on U.S. Government to Fund a National PrEP Program TheBody \| December 20, 2022
	Long-Acting Injectable PrEP as HIV Prevention Scores an A Grade POZ \| December 13, 2022
	PrEP Far More Effective Than Sexual Abstinence In HIV Prevention: HIV Groups CodeBlue - Galen Centre \| December 7, 2022
	COVID-19 Disrupted HIV Testing and Prevention POZ \| December 5, 2022
	Acceptability and usability of oral fluid-based HIV self-testing among female sex workers and men who have sex with men in Morocco BMC Public Health - BioMed Central \| December 5, 2022
	COVID-19 disruptions in HIV testing and prevention highlight need for innovation and investment before the next public health emergency CDC \| December 1, 2022
	Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis Study AIDS Patient Care and STDs Vol. 36, No. 11Behavioral and Psychosocial Research
	Prison program for HIV PrEP enrolls 93% of eligible people Healio \| November 11, 2022
	Presenting a Range of HIV PrEP Options Encourages Uptake Contagion Live \| November 2, 2022
	High PrEP Awareness in US Women, But Only 20% Ever Used It IDWeek 2022, October 19-23, 2022, Washington, DC \| Courtesy of NATAP
	PrEP Interest and Preferences Among US Black and Hispanic Men – A 2021 National Survey IDWeek 2022; October 19-23, 2022; Virtual and Washington, DC \| Courtesy of NATAP
	Perceived influence of alcohol consumption, substance use, and mental health on PrEP adherence and condom use among PrEP-prescribed gay, bisexual, and other men-who-have-sex-with-men: a qualitative investigation BMC Public Health. 2022 Oct 7;22(1):1875. doi: 10.1186/s12889-022-14279-2.
	Increased HIV Infection Linked to Pandemic-Related Access to PrEP Medscape \| October 6, 2022
	Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men AIDS Educ Prev. 2022 Oct;34(5):365-378. doi: 10.1521/aeap.2022.34.5.365.
	Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics NATAP.org \| October 6, 2022
	Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil BMC Public Health. 2022 Sep 12;22(1):1728. doi: 10.1186/s12889-022-14134-4.
	White House Publishes Federal Implementation Plan for National HIV/AIDS Strategy HIV.gov \| August 26, 2022
	Injectable PrEP is safe and effective in preventing HIV/AIDS among trans women, study finds Xtra Magazine \| August 19, 2022
	New data shows inequities in use of medicine that prevents HIV Atlanta Journal-Constitution \| August 15, 2022
	HIV Testing Dropped Among Children, Adolescents During Early COVID-19 American Journal of Managed Care \| July 20, 2022
	Lawyer Who Fought Abortion Rights Takes Aim at HIV Prevention PrEP POZ Magazine \| july 15, 2022
	On-Demand PrEP Works as Well as Daily Pills POZ \| July 12, 2022
	Walgreens helps lead largest coordinated HIV testing event in US Walgreens Newsroom \| July 1, 2022

2019 Archives	2020 Archives	2021 Archives	2022 Archives

PrEP for women in Europe: a systematic literature review

COVID-19 Disrupted HIV Testing and Prevention

COVID-19 disruptions in HIV testing and prevention highlight need for innovation and investment before the next public health emergency